A recent study has demonstrated that reduced baseline Hb level is an unfavorable prognostic marker in advanced NSCLC patients with ICI,30 while other studies in various parts have suggested that low Hb levels are associated with HPD in HCC patients with ICI.31, 32. Here, GSTM1 is linked to non-small cell lung carcinoma.